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Abstract: Mambalgins (Ma) are a novel class of snake venom components that 
have potent analgesic effects mediated through inhibition of acid-sensing ion 
channels (ASICs). We report the chemical synthesis of the 57-residue 
polypeptide Ma-2 using a combination of solid phase peptide synthesis and 
native chemical ligation. The structure of the synthetic toxin determined using 
homonuclear NMR revealed an unusual three-finger toxin fold reminiscent of 
functionally unrelated snake toxins. Electrophysiological analysis of Ma-2 on wild-
type and mutant ASIC1a receptors allowed us to identify α-helix 5 of the channel, 
which borders on the functionally critical acidic pocket, as a major part of the Ma-
2 binding site. This region is also crucial for interaction of ASIC1a with the spider 
toxin PcTx1, suggesting that the binding sites for these toxins substantially 
overlap. This work lays the foundation for SAR studies and further development 
of this promising analgesic peptide. 
 
  
Animal venoms are essentially large combinatorial libraries of bioactive 
molecules, which hold great promise as diagnostic tools and in treatment of 
human diseases.[1] The vast majority of these compounds are disulfide-rich 
polypeptides of 10–80 amino acid residues that adopt highly-ordered 3D 
structures and potently modulate the activity of specific classes of membrane 
proteins such as ion channels, receptors and transporters. Mambalgins are a 
recently discovered class of peptides isolated from the venom of black mamba 
snakes. They are comprised of 57 residues cross-braced by four disulfide 
bridges.[2] The mambalgins are potent blockers of acid-sensing ion channels 
(ASICs) and they show potent central and peripheral analgesic effects in animal 
models without the side effects associated with traditional opioid drugs.[2a] In 
addition to a role in pain perception, this family of proton-gated cation channels 
has been implicated in neurodegeneration, fear and anxiety-related behaviour, 
brain tumour growth and sensory transduction.[3]  
Based on the number and location of the cysteine residues, and the length of the 
inter-cysteine sequences (‘loops’), the mambalgins were proposed to adopt a 
‘three-finger toxin’ (TFT) fold reminiscent of the functionally unrelated short-chain 
neurotoxins commonly found in snake venom.[4] However, the disulfide 
connectivity has not been determined experimentally, the inter-cysteine loops 
show very limited similarity to known TFTs, and the mambalgins possess activity 
not previously observed for TFTs, thereby raising the possibility that the 
mambalgins have a unique 3D fold (see Supporting Information, SI). To address 
this possibility and to establish a robust platform for detailed structure-activity 
relationship studies, we report here the first efficient chemical synthesis and 3D 
structure determination of a member of the mambalgin family (Ma-2). 
We set out to chemically synthesize the entire 57-residue Ma-2 by step-wise 
Fmoc solid-phase peptide synthesis (SPPS). Despite several attempts using 
optimized protocols we were unable to produce even trace amounts of the target 
molecule. Detailed MALDI analysis indicated complete termination of chain 
extension around residue Lys31. 
To circumvent these problems, we turned to Boc chemistry employing a peptide 
fragment ligation approach via Kent’s native chemical ligation (Scheme 1).[5] This 
approach has been instrumental in enabling access to unrelated but similarly 
complex venom-derived disulfide-rich molecules.[6] The synthesis strategy for 
Ma-2 employed three segments with Cys19 and Cys37 serving as ligation sites. 
Temporary protection of Cys19 was realized by substituting this residue with 1,3-
thiazolidine-4-carboxylic acid.[7] Peptide thioesters corresponding to Ma-2[1–18] 
and Ma-2[19–36] were assembled by optimized Boc-SPPS, whereas Ma-2[37–
57] was produced by Fmoc chemistry.[8] All peptide segments were obtained in 
high yield and purity and were subsequently joined using native chemical ligation 
in consecutive one-pot fashion as described previously (see SI for experimental 
details).[6c; 7; 9] The full-length polypeptide was obtained in good yield after HPLC 
purification (33%). Although peptides of this size are generally considered 
amenable to optimized stepwise SPPS,[10] our experience suggests that 
fragment-based assembly may deliver superior results. 
In vitro folding of the polypeptide chain and concomitant formation of the four 
disulfide bridges required optimization. Because of the large number of potential 
disulfide isomers (105), optimization was guided by HPLC analysis and activity 
testing of isolated fractions on rat (r) ASIC1a (see below). Folding was most 
efficient in 100 mM Tris, 500 mM guanidine HCl, pH 8.0 containing a redox 
system of 8 mM reduced glutathione (GSH) and 1 mM oxidized glutathione 
(GSSG). Under these conditions, the reaction reached equilibrium in 24 h and 
the correctly folded Ma-2 was isolated in high purity and acceptable yield after 
HPLC purification (11%). The activity of the synthetic material was assessed 
using two-electrode voltage-clamp electrophysiology on Xenopus laevis oocytes 
heterologeously expressing homomeric rASIC1a and rASIC1b (Figure 2a). 
Synthetic Ma-2 caused a concentration-dependent inhibition with an IC50 of 21 ± 
6 nM for rASIC1a and 103 ± 13 nM for rASIC1b (n = 5). Both values are slightly 
lower (indicating higher potency) than the values previously reported for native 
Ma-2 isolated from snake venom (rASIC1a: 55 nM; rASIC1b: 192 nM),[2a] 
underscoring the high quality of the synthetic material. 
The 3D structure of synthetic Ma-2 was determined using homo-nuclear 2D NMR 
spectroscopy (see SI for details). The solution structure of Ma-2 was calculated 
from 1003 interproton-distance and dihedral-angle restraints using CYANA 3.0[11] 
and refined using CNS.[12] Analysis of the secondary Hα chemical shifts 
compared to those found in random coil peptides revealed several stretches of 
positive chemical shifts indicative of β-sheet formation (SI Figure 3).[13] Several 
residues, most notably Gly36, Arg54 and Arg57, experienced unusually large 
chemical shift differences most likely due to aromatic ring current effects due to 
proximity to Tyr20 and Phe4 (SI Figure 3). Statistical analysis of the inferred 
disulfide bond connectivity in the resultant structure was performed using 
PADLOC[14] and was in agreement with Cys3–Cys19, Cys12–Cys37, Cys41–
Cys49 and Cys50–Cys55. 
An ensemble of the 20 lowest energy structures of Ma-2 is shown in Figure 1a. 
Overall, the structure is well defined with a fold reminiscent of TFTs (SI Figure 4). 
The core of the molecule is stabilized by four disulfide bridges with the same 
connectivity as in other short-chain neurotoxins. Hydrogen-deuterium exchange 
TOCSY experiments indicated several slow exchanging amide protons. In 
particular, backbone amide protons of residues 10, 18, 20 and 52 were still 
detectable after 21 h indicative of strong hydrogen bonding in the core of the 
molecule. Three loops protrude from this core (Figure 1b). The first (residues 4–
11) and the third (residues 42–48) ‘finger’ are structurally well defined, although 
they are shorter than in other TFTs (SI Figure 4). In contrast, the longer middle 
finger (residues 20–36) is disordered from residues Thr23 to Ile33 in agreement 
with TALOS-N predictions that they are flexible.[15] An extensive hydrogen-
bonding network between finger II and III gives rise to a three-pleated antiparallel 
β-sheet. Finger I forms a separate antiparallel β-sheet that is structurally 
constrained by disulfides 3–19 and 12–37. This arrangement of secondary 
structural elements is characteristic for short-chain TFTs (SI Figure 4). Despite 
the similar core, the structure of Ma-2 stands out among TFTs due to its short 
first and third fingers and elongated middle finger. 
The peptide surface contains several clusters of basic or acidic residues (Figure 
2b): 1) a large, positively charged cluster located in the first finger and the core 
domain; 2) Glu43 and Glu45 in the third finger and 3) Arg 28 and Lys31 located 
at the tip of the middle finger. The latter is adjacent to a hydrophobic patch 
formed by Met25, Phe27, Leu30, Leu32 and Leu34. This arrangement is 
reminiscent of psalmotoxin 1 (PcTx1), a potent modulator of ASIC1 isolated from 
tarantula venom (Figure 2b).[16] PcTx1 binds to the acidic pocket at the interface 
between ASIC1 subunits (Figure 2c) that serves as a putative proton-sensing 
site.[17] In doing so, PcTx1 alters the proton sensitivity of the channel and 
stabilizes the desensitized state. Interestingly, mambalgins have been shown to 
decrease ASIC sensitivity to protons suggesting that they might also act as 
gating modifiers and directly or indirectly interfere with the proton sensing 
mechanism.[2a]  
Based on the structural and potentially mechanistic similarities between PcTx1 
and Ma-2 we hypothesized that these toxins might target the same site on 
ASIC1. To test this hypothesis we generated rASIC1a carrying an F350A 
mutation. This residue, which is highly conserved in ASIC1, is located on α-helix 
5 (the ‘thumb region’), just outside the acidic pocket (Figure 2c). An F350L 
mutation was previously shown to essentially abolish PcTx1 action on human 
ASIC1a.[18] The F350A mutant channel functioned similarly to wild type rASIC1a 
albeit with an acidic shift in the pH sensitivity of steady-state desensitisation and 
activation (ΔpH0.5 = –0.17 and –0.37, respectively, see SI Figure 5). This is not 
surprising as Phe350 lies adjacent to the proton-sensing residue Asp349, and 
the F350L mutation in hASIC1a resulted in a similar ~0.4 pH unit acidic shift in 
the pH0.5 of activation.[18] The mutant channel was dramatically less sensitive to 
Ma-2 than wild-type rASIC1a (IC50 > 1 µM, Figure 2a). This more than 50-fold 
drop in toxin efficacy indicates that Phe350 plays a key role in sensitizing ASIC1a 
channels towards Ma-2 as it does towards PcTx1.[18]  
PcTx1 is an equipotent inhibitor of ASIC1a homomers and ASIC1a/2b 
heteromers[18] and potentiates ASIC1b homomers,[19] whereas the mambalgins 
inhibit both ASIC1a and ASIC1b homomers and ASIC1a heteromers.[2a] Thus it 
seems that both peptides can interact, with similar relative efficacy, at the same 
range of ASIC subtypes.[19] In light of their similar subtype selectivity and the fact 
that both toxins require F350 for functional interaction with ASIC1, it seems likely 
that they have similar binding sites, albeit with varied functional consequences 
(PcTx1 can potentiate ASICs,[19] whereas mambalgins so far have only been 
reported to cause inhibition). 
In summary, we demonstrated efficient chemical synthesis of the analgesic 
venom peptide Ma-2. We anticipate that our synthetic approach will not only 
enable detailed structure-activity studies of Ma-2 but that it will also be applicable 
to other family members due to the high degree of sequence conservation within 
the mambalgins. We provide the first experimental proof that mambalgins adopt 
a TFT fold. The mambalgins therefore represent another example of the 
evolutionary divergence of the TFT fold in order to functionally diversify the toxin 
repertoire of venomous snakes.[20] Finally, our functional data suggest that the 
mambalgins bind in close proximity to the acidic pocket of ASIC channels in a 
manner very similar to PcTx1, most likely by insertion of one of their protruding 
‘fingers’. 
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Scheme 1. Synthesis of Ma-2 by native chemical ligation of three peptide 
segments. (a) native chemical ligation: 6 M GdmHCl, 0.2 M sodium phosphate, 
50 mM 4-mercaptophenylacetic acid, 50 mM Tris (2-carboxyethyl) phosphine 
HCl, pH 7.0; (b) ThzàCys conversion: 0.3 M methoxyamine HCl, pH 4.0; (c) 
folding and disulfide formation: 100 mM Tris, 500 mM GdmHCl, 8 mM GSH, 1 
mM GSSG, pH 8.0. 
  
 
Figure 1: Structure of Ma-2. (a) Ensemble of 20 lowest-energy Ma-2 structures 
(PDB ID: 2MFA) superimposed over the backbone of the well-ordered residues 
1–22, 34–41 and 47–57. The N- and the C-termini are labelled and the four 
disulfide bonds are shown in orange. (b) Ribbon representation of the lowest 
energy Ma-2 structure showing three fingers protruding from a disulfide-stabilized 
core. Note the two β-sheets; the antiparallel triple-stranded β-sheet includes 
fingers II and III while the antiparallel double-stranded β-sheet encompasses 
finger I. 
 
 
  
 
Figure 2: Structural and functional characterization of synthetic Ma-2. (a) 
Concentration-response curves for inhibition by synthetic Ma-2 of rASIC1a, 
rASIC1b, or an F350A mutant of rASIC1a (all n = 5). I/Ic: test current/control 
current. The inset shows the pH jump protocol used for channel activation.  (b) 
Surface charge distribution of Ma-2 (upper panel) and PxTc1 (PDB ID: 2KNI, 
lower panel).[21] The hydrophobic patch is coloured white and Ma-2 fingers are 
labelled I-III. (c) Structure of chicken ASIC1 (PDB ID: 4FZ0).[17a] The three 
subunits that form the functional channel are shown in different shades of grey 
and the locations of the acidic pocket (red), Phe350 (yellow) and the thumb 
region (orange) are indicated. 
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Mambalgin fingers pick ASIC's pocket: Efficient chemical synthesis of mambalgin-2 
using native chemical ligation permitted the first structure determination of a member of 
this family of analgesic snake toxins. Electrophysiological analysis suggests that Ma-2 
binds near the acidic pocket on ASIC channels. 
